verzenios
eli lilly nederland b.v. - abemaciclib - krūts audzējs - antineoplastiski līdzekļi - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
levomethadone g.l.pharma 5 mg/ml koncentrāts iekšķīgi lietojama šķīduma pagatavošanai
g.l. pharma gmbh, austria - levometadona hidrohlorīds - koncentrāts iekšķīgi lietojama šķīduma pagatavošanai - 5 mg/ml
onivyde pegylated liposomal (previously known as onivyde)
les laboratoires servier - irinotecan anhydrous free-base - aizkuņģa dziedzera audzēji - antineoplastiski līdzekļi - metastātisku adenocarcinoma, aizkuņģa dziedzera, kombinācijā ar 5 fluorouracil (5 fu) un pieaugušajiem pacientiem, kuriem ir attīstījusies pēc gemcitabine (lv), leucovorin ārstēšana balstīta terapija.
zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - citas gremošanas trakta un metabolisma produkti, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.
co-codamol 500 mg/8 mg tabletes
actavis group ptc ehf., iceland - paracetamolum, codeini phosphas hemihydricus - tablete - 500 mg/8 mg
mycapssa
amryt pharmaceuticals dac - octreotide acetate - akromegālija - hipofīzes un hipotalāma hormoni un analogi - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.
mitaclau 60 mikrogrami tabletes lietošanai zem mēles
norameda uab, lithuania - desmopresīns - tablete lietošanai zem mēles - 60 µg
mitaclau 120 mikrogrami tabletes lietošanai zem mēles
norameda uab, lithuania - desmopresīns - tablete lietošanai zem mēles - 120 µg
mitaclau 240 mikrogrami tabletes lietošanai zem mēles
norameda uab, lithuania - desmopresīns - tablete lietošanai zem mēles - 240 µg
mucofalk orange 3,25 g/5 g granulas
dr. falk pharma gmbh, germany - olveida ceļctekas sēklsedze - granulas - 3,25 g/5 g